CN101972445A - Traditional Chinese medicinal composition for treating myoma of uterus and preparation method thereof - Google Patents
Traditional Chinese medicinal composition for treating myoma of uterus and preparation method thereof Download PDFInfo
- Publication number
- CN101972445A CN101972445A CN2010102249684A CN201010224968A CN101972445A CN 101972445 A CN101972445 A CN 101972445A CN 2010102249684 A CN2010102249684 A CN 2010102249684A CN 201010224968 A CN201010224968 A CN 201010224968A CN 101972445 A CN101972445 A CN 101972445A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- rhizoma
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a novel traditional Chinese medicinal composition for treating myoma of uterus and a preparation method thereof. The traditional Chinese medicinal composition mainly comprises the following raw material medicines: baked pangolin scales, peach seed, red flower, baked frankincense, baked myrrh, salvia miltiorrhiza, scirpus maritimus, zedoary, ground beeltle, sappan wood, dragon's blood, Liujinong, leech (baked abrasive powder), motherwort herb, cowherb seed, szechuan lovage rhizome, rhizoma corydalis, curcuma tuber, green tangerine peel, tangerine peel, Chinese eaglewood, aspongopus, chicken's gizzard-membrane and the like. The traditional Chinese medicinal composition can be prepared into any common oral preparation according to the conventional traditional Chinese medicinal preparation method. The novel traditional Chinese medicinal composition can obviously inhibit the growth of myoma of uterus, controls the development speed of myoma, prevents the degeneration of myoma, abdominal swelling and pain, colporrhagia, palpable mass on the abdomen and pressure symptom, and the like, and has exact clinical curative effect, obvious curative effect and quick response. The traditional Chinese medicinal composition also has the advantages of low cost, basically no toxic or side effect and the like.
Description
?
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of hysteromyoma.Relating in particular to a kind of is the Chinese medicine composition and preparation method thereof of the treatment hysteromyoma of crude drug with the Chinese herbal medicine.
Background technology
Hysteromyoma claims leiomyoma of uterus again, is the modal a kind of benign tumors of female sex organs.How asymptomatic, minority shows as vaginal hemorrhage, and abdominal part touches swollen thing and pressure symptom etc.As when taking place, torsion of pedicle or other situations can cause pain.Common with multiple myomata.The definite etiology unknown of primary disease may be too high with body inner estrogen level, and it is relevant stimulated by estrogen, and modern western medicine is taked gonadal hormone or operative treatment, does not still have other desirable therapies.
The traditional Chinese medical science thinks that hysteromyoma forms because of internal injury caused by excess of seven emotions, visceral dysfunction, qi depression to blood stasis, can be divided into qi depression to blood stasis, two kinds of pattern of syndrome of hyperactivity of fire caused by deficiency of YIN according to clinical symptoms.Because the hysteromyoma growth is very fast, when blood supply is bad, different denaturation can take place.Muscular tumor is bigger, and ischemia is more serious, and then secondary degeneration the more.With compared before the more than ten years, hysteromyoma is more and more favored the middle aged women in thirty or forty years, does not particularly educate, sexual life imbalance and depressed this three class women of disposition, the clinical onset rate has the trend of continuous rising in recent years.
Modern medicine is at clinical a certain symptom treatment, often fall flat, can not find suitable Therapeutic Method, in order to overcome above-mentioned defective, the present invention is based on the differential diagnosis of diseases and the dialectical principle that combines of Chinese traditional treatment hysteromyoma, treating both the principal and secondary aspects of a disease, deficiency and excess is also controlled, inside and outside logical accent, emergency is taken in concurrently, filter out the natural plant of dispersing the stagnated live-QI to relieve the stagnation of QI, circulation of qi promoting intestinal stasis relieving, nourishing YIN to lower pathogenic fire,, be prepared from according to certain weight proportion according to the theory of Chinese medical science prescription.A kind of Chinese medicine composition of evident in efficacy, with low cost, treatment hysteromyoma that toxic and side effects is minimum is provided.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage forms, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be: pill, capsule, tablet, powder, granule or oral liquid etc.
Summary of the invention
Technical problem to be solved by this invention is assorted to overcome above-described shortcoming, and a kind of Chinese medicine composition of treatment hysteromyoma of evident in efficacy, with low cost, almost non-toxic side effect is provided.
Technical problem to be solved by this invention realizes by following technological approaches.
A kind of Chinese medicine composition for the treatment of hysteromyoma of the present invention, the component of main following weight portion is formed:
1～100 part of Squama Manis (processed), 1～50 part in Semen Persicae, 1～50 part on Flos Carthami, 1～50 part of Olibanum (processed), 1～50 part of Myrrha (processed), 1～100 part of Radix Salviae Miltiorrhizae, 1～100 part of RHZOMA SPARGANII, 1～100 part of Rhizoma Curcumae, 1～100 part of Eupolyphaga Seu Steleophaga (baked coke is ground into powder), 1～100 part of Lignum Sappan, 1～50 part of Sanguis Draxonis, Liu posts 1～100 part of farming, 1～50 part of Hirudo (baked coke is ground into powder), 1～200 part of Herba Leonuri, 1～100 part of Radix Achyranthis Bidentatae, 1～120 part of Semen Vaccariae, 1～100 part of Flos Campsis, 1～120 part of Rhizoma Chuanxiong, 1～150 part of Rhizoma Corydalis, 1～120 part of Radix Curcumae, 1～120 part of Fructus Aurantii Immaturus, 1～150 part of Fructus Toosendan, 1～100 part in Rhizoma Curcumae Longae, 1～100 part on Pericarpium Citri Reticulatae Viride, 1～100 part of Lignum Aquilariae Resinatum, 1～120 part of the Radix Linderae, 1～120 part of Rhizoma Cyperi, 1～100 part of Radix Aristolochiae, 1～300 part of Pericarpium Citri Reticulatae, 1～100 part of Pericarpium Arecae, 1～100 part of Bulbus Allii Macrostemonis, 1～100 part of Aspongopus.
Be preferably:
30 parts of Squama Manis (processed), 15 parts in Semen Persicae, 15 parts on Flos Carthami, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts of Radix Salviae Miltiorrhizaes, 20 parts of RHZOMA SPARGANII, 20 parts of Rhizoma Curcumae, 15 parts of Eupolyphaga Seu Steleophagas (baked coke is ground into powder), 20 parts of Lignum Sappans, 15 parts of Sanguis Draxonis, Liu posts 20 parts of farmings, 15 parts of Hirudos (baked coke is ground into powder), 100 parts of Herba Leonuris, 20 parts of Radix Achyranthis Bidentataes, 30 parts of Semen Vaccariae, 20 parts of Flos Campsiss, 30 parts of Rhizoma Chuanxiongs, 100 parts of Rhizoma Corydalis, 30 parts of Radix Curcumaes, 30 parts of Fructus Aurantii Immaturuss, 50 parts of Fructus Toosendans, 30 parts in Rhizoma Curcumae Longae, 30 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Lignum Aquilariae Resinatum, 30 parts of the Radixs Linderae, 50 parts of Rhizoma Cyperi, 30 parts of Radix Aristolochiaes, 150 parts of Pericarpium Citri Reticulataes, 20 parts of Pericarpium Arecae, 20 parts of Bulbus Allii Macrostemonis, 20 parts of Aspongopuss.
The weight portion consumption of each component of Chinese medicine composition of the present invention can also be:
1～100 part of Flos Lonicerae, 1～100 part of Herba Taraxaci, 1～100 part of Radix Scrophulariae, 1～100 part of Radix Sophorae Flavescentis, 1～120 part of Cortex Moutan, 1～100 part of Radix Paeoniae Rubra, 1～150 part of the Radix Paeoniae Alba, 1～50 part of Fructus Crataegi (parched to brown), 1～100 part of Massa Medicata Fermentata, 1～100 part of Radix Notoginseng, 1～100 part of Endothelium Corneum Gigeriae Galli, 1～100 part in Fructus Hordei Germinatus, 1～50 part of Fructus Amomi, 1～50 part of Herba Eupatorii, 1～100 part in Poria, 1～100 part of Ramulus Cinnamomi, 1～50 part of Fructus Liquidambaris, 1～50 part of Herba Lycopodii, 1～100 part of Radix Et Rhizoma Rhei.
Be preferably:
20 parts of Flos Loniceraes, 20 parts of Herba Taraxacis, 20 parts of Radix Scrophulariaes, 20 parts of Radix Sophorae Flavescentiss, 30 parts of Cortex Moutans, 20 parts of Radix Paeoniae Rubra, 30 parts of the Radix Paeoniae Albas, 15 parts of Fructus Crataegi (parched to brown)s, 30 parts of Massa Medicata Fermentata, 30 parts of Radix Notoginseng, 20 parts of Endothelium Corneum Gigeriae Galli, 30 parts in Fructus Hordei Germinatus, 15 parts of Fructus Amomis, 15 parts of Herba Eupatoriis, 30 parts in Poria, 30 parts of Ramulus Cinnamomi, 25 parts of Fructus Liquidambaris, 25 parts of Herba Lycopodiis, 20 parts of Radix Et Rhizoma Rhei.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage form, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be pill, capsule, tablet, powder, granule or oral liquid etc.
Chinese medicine composition of the present invention is opened one's minds based on traditional Chinese medical science the five internal organs differentiation of syndromes of YIN and YANG guiding principle, in conjunction with safe one and Pu innovation theory system " ten thousand diseases ascent theory ", " the five internal organs differentiation of syndromes of YIN and YANG guiding principle ", " three-dimensional conservation regulation and control rule " and clinical treatment " pairing principle " are as instructing, take place in conjunction with disease, development and the rule that changes, classify according to the original new drug system, formation is monarch with " the five internal organs basic function is adjusted; equilibrium between yin and yang coordination side ", " the main pathogenesis of the five internal organs adjustment side " is minister, " therapy of serious disease side " is assistant, " clinical fundamental symptoms symptomatic treatment side " Chinese medicine patent medicine " original new drug system " for making.
The used herbal raw material medicine of the present invention all can be buied from the Chinese medicine shop, and its specification meets national medical standard.
Usage and dosage: dosage of the present invention depends on concrete dosage form, factors such as patient age, body weight, health status.As guidance: for oral administration: 1) capsule: obey 2～5 every day three times at every turn, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The treatment that the present invention is directed to patients with uterine myoma is very effective, various crude drug are coordinated mutually can play together and are at utmost brought into play drug effect, can effectively improve the self-coordination ability of patient's body, significantly improve function and clinical subjective symptoms, have advantage such as have no side effect, expense is lower in addition.
The specific embodiment
Further describe the present invention by the following examples, it should be understood that these embodiment only are used for the purpose of illustration, never are limited to the present invention.
The preparation of [embodiment 1] capsule
Take by weighing each raw material by following weight portion: 30 parts of Squama Manis (processed), 15 parts in Semen Persicae, 15 parts on Flos Carthami, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts of Radix Salviae Miltiorrhizaes, 20 parts of RHZOMA SPARGANII, 20 parts of Rhizoma Curcumae, 15 parts of Eupolyphaga Seu Steleophagas (baked coke is ground into powder), 20 parts of Lignum Sappans, 15 parts of Sanguis Draxonis, Liu posts 20 parts of farmings, 15 parts of Hirudos (baked coke is ground into powder), 100 parts of Herba Leonuris, 20 parts of Radix Achyranthis Bidentataes, 30 parts of Semen Vaccariae, 20 parts of Flos Campsiss, 30 parts of Rhizoma Chuanxiongs, 100 parts of Rhizoma Corydalis, 30 parts of Radix Curcumaes, 30 parts of Fructus Aurantii Immaturuss, 50 parts of Fructus Toosendans, 30 parts in Rhizoma Curcumae Longae, 30 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Lignum Aquilariae Resinatum, 30 parts of the Radixs Linderae, 50 parts of Rhizoma Cyperi, 30 parts of Radix Aristolochiaes, 150 parts of Pericarpium Citri Reticulataes, 20 parts of Pericarpium Arecae, 20 parts of Bulbus Allii Macrostemonis, 20 parts of Aspongopuss.
Grind into after each component mixing with above-mentioned weight and incapsulate promptly after fine powder is crossed 1500 mesh sieves.
The preparation of [embodiment 2] granule
Take by weighing each raw material by following weight portion: 30 parts of Squama Manis (processed), 15 parts in Semen Persicae, 15 parts on Flos Carthami, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts of Radix Salviae Miltiorrhizaes, 20 parts of RHZOMA SPARGANII, 20 parts of Rhizoma Curcumae, 15 parts of Eupolyphaga Seu Steleophagas (baked coke is ground into powder), 20 parts of Lignum Sappans, 15 parts of Sanguis Draxonis, Liu posts 20 parts of farmings, 15 parts of Hirudos (baked coke is ground into powder), 100 parts of Herba Leonuris, 20 parts of Radix Achyranthis Bidentataes, 30 parts of Semen Vaccariae, 20 parts of Flos Campsiss, 30 parts of Rhizoma Chuanxiongs, 100 parts of Rhizoma Corydalis, 30 parts of Radix Curcumaes, 30 parts of Fructus Aurantii Immaturuss, 50 parts of Fructus Toosendans, 30 parts in Rhizoma Curcumae Longae, 30 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Lignum Aquilariae Resinatum, 30 parts of the Radixs Linderae, 50 parts of Rhizoma Cyperi, 30 parts of Radix Aristolochiaes, 150 parts of Pericarpium Citri Reticulataes, 20 parts of Pericarpium Arecae, 20 parts of Bulbus Allii Macrostemonis, 20 parts of Aspongopuss.
Each raw material of above-mentioned weight fraction is mixed, after grinding into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
The preparation of [embodiment 3] tablet
Take by weighing each raw material by following weight portion: 30 parts of Squama Manis (processed), 15 parts in Semen Persicae, 15 parts on Flos Carthami, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts of Radix Salviae Miltiorrhizaes, 20 parts of RHZOMA SPARGANII, 20 parts of Rhizoma Curcumae, 15 parts of Eupolyphaga Seu Steleophagas (baked coke is ground into powder), 20 parts of Lignum Sappans, 15 parts of Sanguis Draxonis, Liu posts 20 parts of farmings, 15 parts of Hirudos (baked coke is ground into powder), 100 parts of Herba Leonuris, 20 parts of Radix Achyranthis Bidentataes, 30 parts of Semen Vaccariae, 20 parts of Flos Campsiss, 30 parts of Rhizoma Chuanxiongs, 100 parts of Rhizoma Corydalis, 30 parts of Radix Curcumaes, 30 parts of Fructus Aurantii Immaturuss, 50 parts of Fructus Toosendans, 30 parts in Rhizoma Curcumae Longae, 30 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Lignum Aquilariae Resinatum, 30 parts of the Radixs Linderae, 50 parts of Rhizoma Cyperi, 30 parts of Radix Aristolochiaes, 150 parts of Pericarpium Citri Reticulataes, 20 parts of Pericarpium Arecae, 20 parts of Bulbus Allii Macrostemonis, 20 parts of Aspongopuss.
Each raw material of above-mentioned weight portion is mixed, after grinding into fine powder and crossing 800～1200 order dusting covers, make tablet promptly.
The preparation of [embodiment 4] pill
Take by weighing each raw material by following weight portion: 30 parts of Squama Manis (processed), 15 parts in Semen Persicae, 15 parts on Flos Carthami, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts of Radix Salviae Miltiorrhizaes, 20 parts of RHZOMA SPARGANII, 20 parts of Rhizoma Curcumae, 15 parts of Eupolyphaga Seu Steleophagas (baked coke is ground into powder), 20 parts of Lignum Sappans, 15 parts of Sanguis Draxonis, Liu posts 20 parts of farmings, 15 parts of Hirudos (baked coke is ground into powder), 100 parts of Herba Leonuris, 20 parts of Radix Achyranthis Bidentataes, 30 parts of Semen Vaccariae, 20 parts of Flos Campsiss, 30 parts of Rhizoma Chuanxiongs, 100 parts of Rhizoma Corydalis, 30 parts of Radix Curcumaes, 30 parts of Fructus Aurantii Immaturuss, 50 parts of Fructus Toosendans, 30 parts in Rhizoma Curcumae Longae, 30 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Lignum Aquilariae Resinatum, 30 parts of the Radixs Linderae, 50 parts of Rhizoma Cyperi, 30 parts of Radix Aristolochiaes, 150 parts of Pericarpium Citri Reticulataes, 20 parts of Pericarpium Arecae, 20 parts of Bulbus Allii Macrostemonis, 20 parts of Aspongopuss.
Each raw material of above-mentioned weight is mixed, grind into cross 600～1000 mesh sieves behind the fine powder after, make pill promptly.
The preparation of [embodiment 5] oral liquid
Take by weighing each raw material by following weight portion: 30 parts of Squama Manis (processed), 15 parts in Semen Persicae, 15 parts on Flos Carthami, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts of Radix Salviae Miltiorrhizaes, 20 parts of RHZOMA SPARGANII, 20 parts of Rhizoma Curcumae, 15 parts of Eupolyphaga Seu Steleophagas (baked coke is ground into powder), 20 parts of Lignum Sappans, 15 parts of Sanguis Draxonis, Liu posts 20 parts of farmings, 15 parts of Hirudos (baked coke is ground into powder), 100 parts of Herba Leonuris, 20 parts of Radix Achyranthis Bidentataes, 30 parts of Semen Vaccariae, 20 parts of Flos Campsiss, 30 parts of Rhizoma Chuanxiongs, 100 parts of Rhizoma Corydalis, 30 parts of Radix Curcumaes, 30 parts of Fructus Aurantii Immaturuss, 50 parts of Fructus Toosendans, 30 parts in Rhizoma Curcumae Longae, 30 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Lignum Aquilariae Resinatum, 30 parts of the Radixs Linderae, 50 parts of Rhizoma Cyperi, 30 parts of Radix Aristolochiaes, 150 parts of Pericarpium Citri Reticulataes, 20 parts of Pericarpium Arecae, 20 parts of Bulbus Allii Macrostemonis, 20 parts of Aspongopuss.
Each raw material of above-mentioned weight is mixed, after three decoctions, three filtrates are mixed, filter, be concentrated into
Normal concentration, put cold, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid promptly.
The clinical observation on the therapeutic effect experiment of [experimental example] traditional Chinese medicine composition for treating patients with uterine myoma of the present invention
One, the physical data of experimental subject: adopt Chinese medicine composition of the present invention to treat 57 routine patients altogether, wherein male 0 example, women 57 examples; The oldest person 48 years old, the age reckling has only 26 years old.
Two, Therapeutic Method:
Usage and dosage: adopt the prepared medicament of the embodiment of the invention, its usage and consumption are as follows: 1) capsule: obey 2～5 every day three times at every turn, and every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The course of treatment: one month is a course of treatment, treats for 6 courses of treatment altogether.
Three, therapeutic evaluation standard
Cure: sign and symptom are improved fully, and be happy, in high spirits.
Produce effects: sign and symptom are significantly improved, and be happy, and spirit is fine.
Effectively: sign and symptom change, and random thoughts have discomfort slightly, but can accept.
Invalid: sign does not have change, symptom such as preceding.
Four, model case:
1, Zhang, the woman is 40 years old, married.
About 8cm * the 5cm in patient uterus * 4cm, visible 3cm in the rear at the bottom of the palace * 2cm enhancing light group, ultrasonic prompting: hysteromyoma, left side hydrosalpinx.Once blood volume was many in menstruation 10-15 days, the light no piece of color, and today, amount subtracted slightly, with shortness of breath and palpitation, light red tongue, white and thin fur, arteries and veins is unable.
Took Chinese medicine composition of the present invention 15, menses are clean, but that health is still felt is unable, and complexion takes a turn for the better.Continue and obeyed Chinese medicine composition of the present invention 1 month, the unable symptom of patient body is clearly better.The clothes Chinese medicine composition of the present invention 2 months that continues, menstrual onset, five days are clean, measures moderately, and color is red, no piece, tongue is normal, white and thin fur, arteries and veins is more preceding effectively, has rosy cheeks.Continue and obeyed Chinese medicine composition of the present invention 2 months, examination in hospital, ultrasonic prompting: the uterus adnexa no abnormality seen illustrates that hysteromyoma and hydrosalpinx all heal.
2, permitted certain, 28 years old, married.
Patient's spring gynecologial examination in 2002, there are the muscular tumor of one 1.8cm * 2cm, non-evident sympton in the uterus.At ordinary times the eumenorrhea, red menses has a small amount of clot, and breast is little to expand, and lower abdomen is made the no pain that expands, and usually body constitution is good, and tongue is normal, stringy pulse.
Took Chinese medicine composition of the present invention 1 month, the patient is smooth and easy through row, and clot disappears, and the breast lower abdomen does not all expand, and continue and obeyed Chinese medicine composition of the present invention 3 months, examination in hospital, ultrasonic prompting: the uterus is normal, and hysteromyoma is healed.
3, the king so-and-so, the woman, 39 years old, married.
The patient is interrupted palace blood more than 3 years repeatedly, and companion's lower abdomen weighs down pain, is diagnosed as hysteromyoma (3.6 * 4.8cm) in certain institute's row B ultrasonic.Not having improvement through how tame hospitalize symptom, bleeds and increases the weight of day by day in the uterus.The patient examines, and disease is seen metrorrhagia, no clot, and the soreness of waist, lower abdomen weighs down pain, light red tongue, white and thin fur, deep-thready pulse.
Took Chinese medicine composition of the present invention 15, patient palace blood stops, and it is light that lower abdomen weighs down alleviation of pain.Continue and obeyed Chinese medicine composition of the present invention 3 months, row uterus ultrasound diagnosis, hysteromyoma is reduced into 1.6 * 1.8cm.Continue and obeyed Chinese medicine composition of the present invention 2 months, the swollen thing in check B ultrasonic uterus disappears, and the patient is healed.
4, go into business certain, the woman is 45 years old, married.
The patient occurs over 3 months that menses are more than, anemia, become thin, symptoms such as myasthenia of limbs, insomnia, sore waist and aching in the waist and the back, in hospital's row ultrasound diagnosis, anterior uterine wall can be visited and (3.8 * 44.6cm) swollen things, left ovary can be visited and (2.6 * 2.8cm) swollen things.Confirm as hysteromyoma, left ovary cyst.Through how tame hospitalize, palace blood is more than.Patient's anemia is heavier, light red tongue, white and thin fur, deep-thready pulse.
Took Chinese medicine composition of the present invention 14, patient palace blood stops, and lower abdomen weighs down pain and obviously alleviates.Continue and obeyed Chinese medicine composition of the present invention 1 month, patient whole body malaise symptoms all disappears, and anemia is improved.Continue and obeyed Chinese medicine composition of the present invention 3 months, row is the uterus B ultrasonic repeatedly, and swollen thing in palace and the swollen thing of ovary disappear, and the patient fully recovers.
5, Zhang, the woman is 48 years old, married.
The patient suffered from hysteromyoma 5 years, in menstruation, 1 in nearly in advance, very then ten days once.Existing B ultrasonic prompting uterus 10
.7 * 7.5 * 4
.8cm, antetheca visible 2
.9 * 2
.2 * 3
.5cm, rear wall visible 2
.3 * 2
.The substantive dark space of 6 * 2.8cm.Last menstrual period so far March unclean, all invalid in hospital's dilatation and curettage, clothes norlutin hemostasis.Inscribe through blood volume many, the red fixture block of color, dizzy unable, the lower abdomen tenesmus, the lazy speech of breathing hard, pale tongue is dark, corpulent tongue is big, indentations at the margin of the tongue, thready pulse.
Took Chinese medicine composition of the present invention 5, menses promptly end, and all diseases have improvement slightly, tongue arteries and veins such as preceding.Continue and obeyed Chinese medicine composition of the present invention 2 months, in the menstrual blood volume, 5-6 days are clean, red menses, and all diseases are improved, B ultrasonic prompting uterus 6
.7 * 4.6 * 3
.4cm sees 1
.9 * 1
.2 * 1
.The substantive dark space of 3cm, body of the tongue is light red, thin fur, moderate pulse.The clothes Chinese medicine composition of the present invention medical treatment 2 months that continues, through how tame hospital repeatedly ultrasound diagnosis all point out intrauterine not see substantive dark space, prove that hysteromyoma is to fully recover.
6, grandson, the woman is 41 years old, married.
Patient patient is hyper-menorrhea before 8 years, and the cycle shortens, and menostaxis removes examination in hospital, does B ultrasonic and finds hysteromyoma.The hysteromyoma of B ultrasonic prompting at that time 6.6 * 5.4cm, the patient does not want to hysterectomize always, the medicine of more oral privately elimination muscular tumors, unsatisfactory curative effect.Recently be B ultrasonic check prompting hysteromyoma 9.9 * 8.8cm.Light red tongue, tongue is white, deep-thready pulse.
Took Chinese medicine composition of the present invention 1 month, the patient body situation before is clearly better, through the more preceding minimizing of amount.Continue and obeyed Chinese medicine composition of the present invention 1 month, the ultrasound diagnosis prompting, hysteromyoma is reduced into 7.0 * 5.2cm.Continue and obeyed Chinese medicine composition of the present invention 3 months, menstruation recovery is normal, and the swollen thing in check B ultrasonic uterus disappears, and the patient is healed.
7, Lin, the woman is 35 years old, married.
The patient is unit health check-up discovery hysteromyoma before 4 years, hyper-menorrhea, menostaxis.Time sense lower abdomen discomfort, each menorrhagia, menostaxis, conscious waist and sacrum pain, companion's urine urgency-frequency, anoperineal portion is extremely uncomfortable, falling to expand sense obviously.Dimly red tongue, limit have purpura point, deep and stringy pulse.
Took Chinese medicine composition of the present invention 1 month, all diseases of patient are all taken a favorable turn, and waist and sacrum pain is alleviated, and weigh down the sense of expanding and obviously alleviate, and menstrual blood volume is more preceding less.The clothes Chinese medicine composition of the present invention 3 months that continues, patient body in order, menstruation recovery is normal, row uterus ultrasound diagnosis, the swollen thing in prompting uterus disappears, the patient is healed.
8, the king so-and-so, the woman, 40 years old, married.
The patient is preceeded menorrhea over the past half year, menorrhagia, and the state of an illness increases the weight of gradually, and more than existing January of leaking down when examining is surplus, accompany scorching hotly in the heart, and nipple is itched, and distending pain of the breast leads and axillary fossa, removes examination in hospital, does B ultrasonic discovery hysteromyoma.Red tongue, the few Tianjin of tongue, stringy and thready pulse.
Took Chinese medicine composition of the present invention 7, the patient leaks down to stop, and distending pain of the breast obviously alleviates.Continue and obeyed Chinese medicine composition of the present invention 2 months, patient whole body malaise symptoms all disappears, and menstruation is normal substantially.Continue and obeyed Chinese medicine composition of the present invention 3 months, hospital's uterus ultrasound diagnosis, the prompting hysteromyoma disappears, patient's recovery from illness.
Five, therapeutic outcome:
In the 57 routine cases of being accepted for medical treatment,, wherein cure 31 examples through treatment in 6 months, produce effects 12 examples, effective 8 examples, invalid 6 examples, total effective rate reaches 89 %.The result shows that Chinese medicine composition of the present invention has extremely significant curative effect to the treatment patients with uterine myoma.
Claims (7)
1. Chinese medicine composition for the treatment of hysteromyoma is characterized in that: mainly contain following bulk drugs and form:
1～100 part of Squama Manis (processed), 1～50 part in Semen Persicae, 1～50 part on Flos Carthami, 1～50 part of Olibanum (processed), 1～50 part of Myrrha (processed), 1～100 part of Radix Salviae Miltiorrhizae, 1～100 part of RHZOMA SPARGANII, 1～100 part of Rhizoma Curcumae, 1～100 part of Eupolyphaga Seu Steleophaga (baked coke is ground into powder), 1～100 part of Lignum Sappan, 1～50 part of Sanguis Draxonis, Liu posts 1～100 part of farming, 1～50 part of Hirudo (baked coke is ground into powder), 1～200 part of Herba Leonuri, 1～100 part of Radix Achyranthis Bidentatae, 1～120 part of Semen Vaccariae, 1～100 part of Flos Campsis, 1～120 part of Rhizoma Chuanxiong, 1～150 part of Rhizoma Corydalis, 1～120 part of Radix Curcumae, 1～120 part of Fructus Aurantii Immaturus, 1～150 part of Fructus Toosendan, 1～100 part in Rhizoma Curcumae Longae, 1～100 part on Pericarpium Citri Reticulatae Viride, 1～100 part of Lignum Aquilariae Resinatum, 1～120 part of the Radix Linderae, 1～120 part of Rhizoma Cyperi, 1～100 part of Radix Aristolochiae, 1～300 part of Pericarpium Citri Reticulatae, 1～100 part of Pericarpium Arecae, 1～100 part of Bulbus Allii Macrostemonis, 1～100 part of Aspongopus.
2. according to the described Chinese medicine composition of claim 1, it is characterized in that: the weight portion of each crude drug is:
30 parts of Squama Manis (processed), 15 parts in Semen Persicae, 15 parts on Flos Carthami, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts of Radix Salviae Miltiorrhizaes, 20 parts of RHZOMA SPARGANII, 20 parts of Rhizoma Curcumae, 15 parts of Eupolyphaga Seu Steleophagas (baked coke is ground into powder), 20 parts of Lignum Sappans, 15 parts of Sanguis Draxonis, Liu posts 20 parts of farmings, 15 parts of Hirudos (baked coke is ground into powder), 100 parts of Herba Leonuris, 20 parts of Radix Achyranthis Bidentataes, 30 parts of Semen Vaccariae, 20 parts of Flos Campsiss, 30 parts of Rhizoma Chuanxiongs, 100 parts of Rhizoma Corydalis, 30 parts of Radix Curcumaes, 30 parts of Fructus Aurantii Immaturuss, 50 parts of Fructus Toosendans, 30 parts in Rhizoma Curcumae Longae, 30 parts on Pericarpium Citri Reticulatae Viride, 20 parts of Lignum Aquilariae Resinatum, 30 parts of the Radixs Linderae, 50 parts of Rhizoma Cyperi, 30 parts of Radix Aristolochiaes, 150 parts of Pericarpium Citri Reticulataes, 20 parts of Pericarpium Arecae, 20 parts of Bulbus Allii Macrostemonis, 20 parts of Aspongopuss.
3. according to the described Chinese medicine composition of claim 1, wherein crude drug also has:
1～100 part of Flos Lonicerae, 1～100 part of Herba Taraxaci, 1～100 part of Radix Scrophulariae, 1～100 part of Radix Sophorae Flavescentis, 1～120 part of Cortex Moutan, 1～100 part of Radix Paeoniae Rubra, 1～150 part of the Radix Paeoniae Alba, 1～50 part of Fructus Crataegi (parched to brown), 1～100 part of Massa Medicata Fermentata, 1～100 part of Radix Notoginseng, 1～100 part of Endothelium Corneum Gigeriae Galli, 1～100 part in Fructus Hordei Germinatus, 1～50 part of Fructus Amomi, 1～50 part of Herba Eupatorii, 1～100 part in Poria, 1～100 part of Ramulus Cinnamomi, 1～50 part of Fructus Liquidambaris, 1～50 part of Herba Lycopodii, 1～100 part of Radix Et Rhizoma Rhei.
4. according to the described Chinese medicine composition of claim 3, wherein the weight portion of each component is:
20 parts of Flos Loniceraes, 20 parts of Herba Taraxacis, 20 parts of Radix Scrophulariaes, 20 parts of Radix Sophorae Flavescentiss, 30 parts of Cortex Moutans, 20 parts of Radix Paeoniae Rubra, 30 parts of the Radix Paeoniae Albas, 15 parts of Fructus Crataegi (parched to brown)s, 30 parts of Massa Medicata Fermentata, 30 parts of Radix Notoginseng, 20 parts of Endothelium Corneum Gigeriae Galli, 30 parts in Fructus Hordei Germinatus, 15 parts of Fructus Amomis, 15 parts of Herba Eupatoriis, 30 parts in Poria, 30 parts of Ramulus Cinnamomi, 25 parts of Fructus Liquidambaris, 25 parts of Herba Lycopodiis, 20 parts of Radix Et Rhizoma Rhei.
5. according to claim 1,2,3 or 4 described any Chinese medicine compositions, it is characterized in that: can be prepared into any oral formulations commonly used according to the method for Chinese medicinal of routine.
6. according to the described Chinese medicine composition of claim 5, it is characterized in that: described oral formulations is pill, capsule, tablet, powder, granule or oral liquid.
7. the application of the described any Chinese medicine composition of claim 1～6 in preparation treatment hysteromyoma medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102249684A CN101972445A (en) | 2010-07-13 | 2010-07-13 | Traditional Chinese medicinal composition for treating myoma of uterus and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102249684A CN101972445A (en) | 2010-07-13 | 2010-07-13 | Traditional Chinese medicinal composition for treating myoma of uterus and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101972445A true CN101972445A (en) | 2011-02-16 |
Family
ID=43572378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102249684A Pending CN101972445A (en) | 2010-07-13 | 2010-07-13 | Traditional Chinese medicinal composition for treating myoma of uterus and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101972445A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102988892A (en) * | 2012-11-26 | 2013-03-27 | 葛才志 | Medicament for treating hysteromyoma and ovarian cysts |
| CN103272180A (en) * | 2013-05-23 | 2013-09-04 | 王成红 | Externally-applied Chinese medicine preparation for treating hysteromyoma |
| CN103285291A (en) * | 2013-06-18 | 2013-09-11 | 冯宇伟 | Medicine for treating uterine fibroid and ovarian cyst and preparation method thereof |
| CN104338045A (en) * | 2013-07-23 | 2015-02-11 | 陈学媛 | Drug for treating gynecologic inflammation and preparation method thereof |
| CN104367660A (en) * | 2014-11-19 | 2015-02-25 | 青岛祥翔生物医药科技有限公司 | Traditional Chinese medicine for treating phlegm-damp stasis syndrome type abdominal mass |
| CN104398972A (en) * | 2014-11-05 | 2015-03-11 | 山东瑞康生命科技有限公司 | Traditional Chinese medicine treating qi-stagnation blood-stasis type hysteromyoma and preparation method |
| CN104474456A (en) * | 2014-11-20 | 2015-04-01 | 界首骨科医院 | Traditional Chinese medicinal pill for treating hysteromyoma |
| CN105748813A (en) * | 2016-04-06 | 2016-07-13 | 王保安 | Traditional Chinese medicine composition for preventing/treating hysteromyoma as well as preparation method and application thereof |
| CN105797046A (en) * | 2016-03-14 | 2016-07-27 | 李玲 | Traditional Chinese medicine composition for uterine fibroid treatment and postoperative nursing |
-
2010
- 2010-07-13 CN CN2010102249684A patent/CN101972445A/en active Pending
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102988892A (en) * | 2012-11-26 | 2013-03-27 | 葛才志 | Medicament for treating hysteromyoma and ovarian cysts |
| CN103272180A (en) * | 2013-05-23 | 2013-09-04 | 王成红 | Externally-applied Chinese medicine preparation for treating hysteromyoma |
| CN103272180B (en) * | 2013-05-23 | 2014-07-23 | 王成红 | Externally-applied Chinese medicine preparation for treating hysteromyoma |
| CN103285291A (en) * | 2013-06-18 | 2013-09-11 | 冯宇伟 | Medicine for treating uterine fibroid and ovarian cyst and preparation method thereof |
| CN104338045A (en) * | 2013-07-23 | 2015-02-11 | 陈学媛 | Drug for treating gynecologic inflammation and preparation method thereof |
| CN104398972A (en) * | 2014-11-05 | 2015-03-11 | 山东瑞康生命科技有限公司 | Traditional Chinese medicine treating qi-stagnation blood-stasis type hysteromyoma and preparation method |
| CN104367660A (en) * | 2014-11-19 | 2015-02-25 | 青岛祥翔生物医药科技有限公司 | Traditional Chinese medicine for treating phlegm-damp stasis syndrome type abdominal mass |
| CN104367660B (en) * | 2014-11-19 | 2016-12-28 | 烟台瑞智生物医药科技有限公司 | A kind of Chinese medicine treating phlegm-damp stasis pattern of syndrome abdominal mass |
| CN104474456A (en) * | 2014-11-20 | 2015-04-01 | 界首骨科医院 | Traditional Chinese medicinal pill for treating hysteromyoma |
| CN104474456B (en) * | 2014-11-20 | 2017-12-22 | 界首骨科医院 | A kind of traditional Chinese medicine pill for being used to treat fibroid |
| CN105797046A (en) * | 2016-03-14 | 2016-07-27 | 李玲 | Traditional Chinese medicine composition for uterine fibroid treatment and postoperative nursing |
| CN105748813A (en) * | 2016-04-06 | 2016-07-13 | 王保安 | Traditional Chinese medicine composition for preventing/treating hysteromyoma as well as preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101766790B (en) | Chinese medicine composite for treating chronic atrophic gastritis and preparation method thereof | |
| CN101780247B (en) | Traditional Chinese medicine composition for treating acute enteritis and preparation method thereof | |
| CN101869691B (en) | Chinese medicinal composition for treating dysmenorrhea and preparation method thereof | |
| CN101757542B (en) | Traditional Chinese medicine composition for treating colonitis and preparation method | |
| CN101810833B (en) | Chinese medicinal composition for treating edema and preparation method thereof | |
| CN101972445A (en) | Traditional Chinese medicinal composition for treating myoma of uterus and preparation method thereof | |
| CN101711851B (en) | Traditional Chinese medicine composition for treating symptoms of renal calculus and preparation method thereof | |
| CN101966322A (en) | Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof | |
| CN101966320A (en) | Chinese medicinal composition for treating proliferation of mammary gland and preparation method thereof | |
| CN101816742A (en) | Chinese medicinal composition for treating hemorrhoids and preparation method thereof | |
| CN101966313A (en) | Chinese medicinal composition for treating female infertility and preparation method thereof | |
| CN101757566A (en) | Traditional Chinese medicine composition for treating colon cancer and preparation method thereof | |
| CN101780254B (en) | Traditional Chinese medicine compound for treating intestinal tumor | |
| CN101966301A (en) | Chinese medicinal composition for treating pelvic inflammation and preparation method thereof | |
| CN101785847A (en) | Traditional Chinese medicine combination for intestinal caner treatment and preparation method thereof | |
| CN101797352B (en) | Chinese medicinal composition for treating lassitude hypodynamia and preparation method thereof | |
| CN101810816A (en) | Chinese medicinal composition for treating abnormal vaginal discharge and preparation method thereof | |
| CN101810835A (en) | Chinese medicinal composition for treating purpura and preparation method thereof | |
| CN101670060A (en) | Traditional Chinese medicine composition for treating such diseases as hepatic stagnation, chest stuffiness and distension and preparation method | |
| CN101966321A (en) | Traditional Chinese medicinal composition for treating breast cancer and preparation method thereof | |
| CN104857478A (en) | Medical composition for treating hysteromyoma and preparation method of medical composition | |
| CN101972432A (en) | Chinese medicinal composition for treating diarrhea associated with menstruation and preparation method thereof | |
| CN101966318A (en) | Traditional Chinese medicinal composition for curing breast pain during menstruation and preparation method thereof | |
| CN101810823B (en) | Chinese medicinal composition for treating renal cyst diseases and use of preparing medicine | |
| CN101966289A (en) | Chinese medicinal composition for treating frigidity and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20110216 |